Intracranial non-myxoid angiomatoid fibrous histiocytoma with

Ewing sarcoma breakpoint region 1 gene angiomatoid fibrous histiocytoma anthracycline central nervous system tumor doxorubicin safety

Journal

Molecular and clinical oncology
ISSN: 2049-9450
Titre abrégé: Mol Clin Oncol
Pays: England
ID NLM: 101613422

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 03 07 2020
accepted: 21 10 2021
entrez: 31 5 2021
pubmed: 1 6 2021
medline: 1 6 2021
Statut: ppublish

Résumé

Angiomatoid fibrous histiocytoma (AFH) is a rare soft tissue tumor that has only been reported in the central nervous system in case reports. After surgery, patients exhibit tumor recurrence. Pathological diagnosis of AHF remains difficult, especially in sites other than skin. AFH can harbor characteristic translocations implying that the Ewing sarcoma breakpoint region 1 gene (

Identifiants

pubmed: 34055346
doi: 10.3892/mco.2021.2293
pii: MCO-0-0-02293
pmc: PMC8138849
doi:

Types de publication

Journal Article

Langues

eng

Pagination

131

Informations de copyright

Copyright: © Garnier et al.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

BMC Musculoskelet Disord. 2017 Jan 23;18(1):31
pubmed: 28114920
Genes Chromosomes Cancer. 2007 Dec;46(12):1051-60
pubmed: 17724745
Pediatr Neurosurg. 2019;54(5):347-353
pubmed: 31430747
Br J Neurosurg. 2021 Apr;35(2):233-235
pubmed: 29540076
Cancer. 1979 Dec;44(6):2147-57
pubmed: 228836
Brain Pathol. 2018 Mar;28(2):183-191
pubmed: 28281318
Pediatr Blood Cancer. 2017 Jun;64(6):
pubmed: 28012233
J Neuropathol Exp Neurol. 2020 Mar 1;79(3):347-351
pubmed: 32016322
Am J Surg Pathol. 2008 Mar;32(3):478-84
pubmed: 18300800
Arch Pathol Lab Med. 2015 May;139(5):674-82
pubmed: 25927151
Cell. 1989 Nov 17;59(4):675-80
pubmed: 2573431
World Neurosurg. 2019 Jun;126:113-119
pubmed: 30831299
Nucleic Acids Res. 1993 Jun 25;21(12):2907-11
pubmed: 8332500
Am J Surg Pathol. 2012 Jul;36(7):e1-e11
pubmed: 22510762
J Neurosurg. 2010 May;112(5):978-82
pubmed: 19731989
Cureus. 2019 Mar 18;11(3):e4261
pubmed: 31139520
World Neurosurg. 2016 Dec;96:403-409
pubmed: 27667574
Histopathology. 2018 Apr;72(5):880-883
pubmed: 29143432
J Neuropathol Exp Neurol. 2018 Jul 1;77(7):537-541
pubmed: 29788195
Am J Surg Pathol. 2017 Apr;41(4):482-490
pubmed: 28009602
Hum Pathol. 1999 Nov;30(11):1336-43
pubmed: 10571514
Brain Tumor Pathol. 2020 Apr;37(2):76-80
pubmed: 32215804
Cephalalgia. 2015 Dec;35(14):1334-6
pubmed: 25900984
Med J Malaysia. 2019 Jun;74(3):234-236
pubmed: 31256181
Cancer. 1994 Aug 1;74(3):962-4
pubmed: 8039125

Auteurs

Louis Garnier (L)

Department of Neuro-Oncology, East Group Hospital, Hospices Civils de Lyon, 69677 Lyon, France.
Department of Clinical Sciences, Claude Bernard Lyon 1 University, 69008 Lyon, France.

Tanguy Fenouil (T)

Department of Pathology, East Group Hospital, Hospices Civils de Lyon, 69677 Lyon, France.
Department of Clinical Sciences, Claude Bernard Lyon 1 University, INSERM U1052, CNRS UMR5286, Léon Bérard Center, Cancer Research Center of Lyon, 69667 Lyon, France.

Daniel Pissaloux (D)

Department of Clinical Sciences, Claude Bernard Lyon 1 University, INSERM U1052, CNRS UMR5286, Léon Bérard Center, Cancer Research Center of Lyon, 69667 Lyon, France.
Department of Biopathology, Léon Bérard Center, 69008 Lyon, France.

Roxana Ameli (R)

Department of Neuro-Radiology, East Group Hospital, Hospices Civils de Lyon, 69677 Lyon, France.

François Ducray (F)

Department of Neuro-Oncology, East Group Hospital, Hospices Civils de Lyon, 69677 Lyon, France.
Department of Clinical Sciences, Claude Bernard Lyon 1 University, 69008 Lyon, France.

David Meyronet (D)

Department of Clinical Sciences, Claude Bernard Lyon 1 University, 69008 Lyon, France.
Department of Pathology, East Group Hospital, Hospices Civils de Lyon, 69677 Lyon, France.
Cancer Research Center of Lyon, INSERM U1052, CNRS UMR5286, Cancer Cell Plasticity Department, Transcriptome Diversity in Stem Cells Laboratory, 69008 Lyon, France.

Jerome Honnorat (J)

Department of Neuro-Oncology, East Group Hospital, Hospices Civils de Lyon, 69677 Lyon, France.
Department of Clinical Sciences, Claude Bernard Lyon 1 University, 69008 Lyon, France.
Department of NeuroMyoGene Institute, INSERM U1217/CNRS UMR 5310, Lyon University, Claude Bernard Lyon 1 University, 69008 Lyon, France.

Classifications MeSH